Pfizers CEO liquidates 5.6 Million of it’s STOCK

According to CNBC after announcing the Covid-19 vaccine was more than 90% effective the CEO of Pfizer (Albert Bourla) got rid of 132,508 worth of shares in the company that represented $5.6 million stocks in total. The transaction was allegedly apart of a “pre-scheduled” “trading plan”. This sale came after it’s shares rose 15% on the companies vaccine news. It is now being reported that the antidote has some pretty unpleasant “side effects” which mimic “a hangover.” If a company anticipates success then doesn’t it’s stock continue to rise? If the vaccine is indeed safe for the public shouldn’t profits/gains continue to increase? Is this business as usual or funny business?

BY: BEWITTY Staff

Published by